KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Tax Rate (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Tax Rate for 11 consecutive years, with 112.54% as the latest value for Q4 2025.

  • On a quarterly basis, Tax Rate fell 15425.0% to 112.54% in Q4 2025 year-over-year; TTM through Dec 2025 was 21.37%, a 304.0% decrease, with the full-year FY2025 number at 21.37%, down 315.0% from a year prior.
  • Tax Rate was 112.54% for Q4 2025 at Supernus Pharmaceuticals, down from 22.09% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 495.5% in Q3 2022 to a low of 112.54% in Q4 2025.
  • A 5-year average of 35.25% and a median of 24.16% in 2021 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: soared 46995bps in 2022, then crashed -24731bps in 2024.
  • Supernus Pharmaceuticals' Tax Rate stood at 19.06% in 2021, then surged by 244bps to 27.51% in 2022, then crashed by -154bps to 14.85% in 2023, then soared by 381bps to 41.71% in 2024, then plummeted by -370bps to 112.54% in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Tax Rate are 112.54% (Q4 2025), 22.09% (Q3 2025), and 34.98% (Q2 2025).